started · updated
Harokopio University launches My NutriPath obesity support program
Harokopio University has launched My NutriPath, a free teleconsultation service designed to support patients beginning injectable therapies for obesity management. The initiative, supported by pharmaceutical sponsor Pharmaserve-Lilly, aims to provide a holistic approach by combining medical treatment with professional nutritional guidance.
Participants in the program receive five teleconsultation sessions with a specialized dietitian during their first six months. These sessions focus on creating personalized nutritional plans, education for sustainable lifestyle changes, and guidance tailored to specific therapeutic goals. An additional telephone assessment session is scheduled within the first year of enrollment.
Eligibility requires a referral from a treating physician at the start of treatment. The program is available to patients using any approved injectable therapy for obesity who meet specific criteria: a Body Mass Index (BMI) of 30 kg/m² or greater, or a BMI between 27 and 30 kg/m² accompanied by at least one comorbidity, such as hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or type 2 diabetes.
Entities
Harokopio University · My NutriPath · PharmaServ-Lilly · Pharmaserve-Lilly